MedTrace Logo

Incentives and Glucose Adherence in Diabetes

NCT03338829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2025-07-30

Study results available
· View outcomes & findings →

Summary

Diabetes in pregnancy carries significant pregnancy specific risks and requires frequent glucose monitoring to reduce these risks. This project compares the effect of two incentive schemes on adherence rates of glucose testing in pregnancy.

Conditions

  • Diabetes in Pregnancy

Interventions

BEHAVIORAL

Positive incentive

Compensation is paid for each glucose test completed

BEHAVIORAL

Loss aversion

Fixed compensation is offered to patients and they can earn a range of compensation at the completion of pregnancy depending on overall glucose testing adherence

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Janet Andrews, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-05
Primary Completion
2019-12-18
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338829 on ClinicalTrials.gov